Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/RXRX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Recursion Pharmaceuticals Inc (RXRX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

RXRX trades at $3.23, up 1.89% today, showing volatile price action amid mixed technical signals. The company reported Q2 2026 earnings miss with revenues declining year-over-year to $54M, while maintaining a substantial net loss of -$519M. Analyst consensus is mixed with 40% buy ratings, though technical indicators show neutral momentum with RSI at 59. Recent news highlights pipeline progress with Genentech collaboration advancing a neuroscience target.
Outlook remains speculative given deep losses and high cash burn, though partnerships and AI-driven drug discovery platform offer long-term potential. Key risks include execution challenges, revenue volatility, and dependence on collaboration funding. The stock presents high-risk opportunity for investors betting on biotech innovation turnaround.
Read full analysis

Key Stats

  • Market Cap
    $1.71B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $6.79
  • 52W Low
    $2.84
  • Typical Hold Time
    -
  • Enterprise Value
    $1.23B
  • Div Yield
    -
  • Trading Activity
    -
$3.23
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Track Recursion Pharmaceuticals Inc (RXRX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Buy and sell Recursion Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Most Recent News

Content is generated by Aura AI

Replimune's melanoma drug gets FDA nod but faces legal probe over data practices

Replimune Group's melanoma drug Tudriqev received accelerated FDA approval after two prior rejections, based on a 24.20% response rate in trials. Following this, BMO Capital raised its price target for Replimune stock from $16 to $20, indicating stro...

Market News
3 hours ago
Gordon Thompson
Neutral
pluang ai news

Digital Realty backs Texas Governor Abbott's plan for responsible data center growth amid rising AI demand.

Digital Realty, the largest cloud- and carrier-neutral data center platform, supports Texas Governor Abbott's initiative for responsible and transparent data center investment in Texas. The company emphasizes collaboration with officials and communit...

Market News
3 hours ago
Na
Bullish
news icon
pluang ai news

Verisk Analytics CEO Lee Shavel sells 2,500 shares for $550,000.

Verisk Analytics CEO Lee Shavel has sold 2,500 shares of the company, generating $550,000 from the transaction. This sale may indicate personal portfolio adjustments or strategic financial planning by the CEO. Investors might watch for any further in...

Market News
4 hours ago
Sarah Sidlow
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $1.71B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $6.79
  • 52W Low
    $2.84
  • Typical Hold Time
    -
  • Enterprise Value
    $1.23B
  • Div Yield
    -
  • Trading Activity
    -
$3.23
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Track Recursion Pharmaceuticals Inc (RXRX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Buy and sell Recursion Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!